Core Scientific, Inc./tx (CORZ) Form 8-K — Nov 5, 2026
Core Scientific (CORZ) reported Q3 2026 total revenue of $232.9M, up ~187% year over year, with colocation revenue rising nearly 60% sequentially to $215.4M as billing reached 485 MW of capacity. Adjusted EBITDA more than tripled sequentially to $133.6M at a 57% margin, while GAAP net income of $1.18B was driven primarily by a non-cash $1.03B gain in the fair value of warrants tied to the stock's move. The company is nearing full delivery of its ~590 MW CoreWeave buildout (early 2027 completion) with ~$850M average annualized colocation revenue, and a 530 MW AMD-backed neocloud lease with initial delivery expected in early 2027.
Key figures
- Eps
- 0.47
- Revenue
- 232866000
- Net Income
- 1178130000
- Total Debt
- 4302175000
- Revenue Yoy
- 187% (vs $81.1M in Q3 2025)
- Total Assets
- 5935714000
- Cash Position
- 803941000
- Billing mw
- 485
- Gross margin
- 53%
- Capex q3 2026
- 985100000
- Contracted power
- ~1.1 GW
- Coreweave leased mw
- 590
- Gross profit q3 2026
- 123272000
- Adjusted ebitda margin
- 57%
- Amd neocloud leased mw
- 530
- Adjusted ebitda q3 2026
- 133568000
- Fully diluted market cap
- $6.5B
- Total contracted revenue
- $24B+
- Colocation revenue q2 2026
- 136669000
- Colocation revenue q3 2026
- 215432000
- Warrant fair value gain q3
- 1034358000
- Coreweave annualized revenue
- ~$850M
- Annualized colocation revenue
- over $700 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.